Optical imaging developer VisEn Medical of Woburn, MA, has raised Series B financing, the company reported.
Merck Capital Ventures and Flagship Ventures co-lead the $7 million investment round, which also included the Bollard Group and other investors. Per Lofberg, president and CEO of Merck Capital Ventures, will join VisEn Medical's board of directors.
VisEn was founded in 2000 by researchers and clinicians at the Massachusetts General Hospital and Harvard Medical School in Boston.
By AuntMinnie.com staff writers
October 25, 2007
Related Reading
VisEn brings molecular imaging probe to market, June 7, 2007
VisEn, Merck to develop molecular imaging agents, March 6, 2007
VisEn, Olympus expand distribution relationship, December 11, 2006
Olympus, VisEn ink Japanese deal, December 11, 2006
VisEn debuts optical imaging probes, March 28, 2006
Copyright © 2007 AuntMinnie.com
